HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.

Abstract
Targeted radiotherapy for pigmented melanoma with 3,7-(dimethylamino) phenazathionium chloride [methylene blue (MTB)] labelled with Astatine-211 (211At; alpha-particle emitter) proved to be very effective in animal model systems. Since the results justified an introduction of the treatment to the clinic, the aim of the bio-distribution studies using [123I]-MTB and [131I]-MTB in patients was to confirm selectiveness of radiolabelled MTB uptake in melanoma lesions. The investigations were carried out using planar and SPECT (single photon emission computed tomography) gamma-cameras. A stable uptake of radioiodinated MTB was found in pigmented melanomas in man, with tumour/surrounding tissue and tumour/blood ratios amounting to 9 at 19 h after a single i.v. injection. A time-dependent kinetics of radioiodinated MTB distribution was similar to that observed in human melanoma-bearing athymic mice. Blood radioactivity decreased by about 90% during the first 2.5 min after i.v. injection of the compound (T1/2biol = 0.58 min). Its retention time in various organs was either the same or very similar to that characteristic of the blood. A rapid uptake of radioiodinated MTB in the liver and kidneys confirmed the importance of these organs in excreting the compound: 25-30% of the radioactivity administered was expelled with urine over the first 24 h after the injection. There was no obvious retention of radioiodinated MTB in the brain over the observation period and in the eyes for at least the first 14 h.
AuthorsE M Link, D C Costa, D Lui, P J Ell, P J Blower, M F Spittle
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 35 Issue 3 Pg. 331-41 ( 1996) ISSN: 0284-186X [Print] England
PMID8679265 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Coloring Agents
  • Iodine Radioisotopes
  • Methylene Blue
Topics
  • Adult
  • Aged
  • Animals
  • Brain (metabolism)
  • Coloring Agents (administration & dosage, pharmacokinetics)
  • Disease Models, Animal
  • Eye (metabolism)
  • Female
  • Humans
  • Injections, Intravenous
  • Iodine Radioisotopes (blood, pharmacokinetics, urine)
  • Kidney (metabolism)
  • Liver (metabolism)
  • Male
  • Melanoma (diagnostic imaging, radiotherapy)
  • Methylene Blue (administration & dosage, pharmacokinetics)
  • Mice
  • Mice, Nude
  • Middle Aged
  • Neoplasm Transplantation
  • Time Factors
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon (methods)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: